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Nitric oxide is an endogenous thiol-reactive molecule
that modulates the functions of many regulatory proteins
by a thiol-redox mechanism. NO has now been shown to
inhibit the activation of apoptosis signal-regulating ki-
nase 1 (ASK1) in murine fibrosarcoma L929 cells through
such a mechanism. Exposure of L929 cells to interferon-
resulted in the endogenous production of NO and in inhi-
bition of the activation of ASK1 by hydrogen peroxide.
The interferon--induced inhibition of ASK1 activity was
blocked by NG-nitro-L-arginine, an inhibitor of NO syn-
thase. Furthermore, the NO donor S-nitro-N-acetyl-DL-
penicillamine (SNAP) inhibited ASK1 activity in vitro,
and this inhibition was reversed by thiol-reducing agents
such as dithiothreitol and -mercaptoethanol. SNAP did
not inhibit the kinase activities of MKK3, MKK6, or p38 in
vitro. The inhibition of ASK1 by interferon- was not
changed by 1H- (1,2,4)oxadiazolo[4,3-]quinoxalin-1-one,
an inhibitor of guanylyl cyclase nor was it mimicked by
8-bromo-cyclic GMP. Site-directed mutagenesis revealed
that replacement of cysteine 869 of ASK1 by serine ren-
dered this protein resistant to the inhibitory effects both
of interferon- in intact cells and of SNAP in vitro. Co-
immunoprecipitation data showed that NO production
inhibited a binding of ASK1, but not ASK1(C869S), to
MKK3 or MKK6. Moreover, interferon- induced the S-
nitrosylation of endogenous ASK1 in L929 cells. Together,
these results suggest that NO mediates the interferon--
induced inhibition of ASK1 in L929 cells through a thiol-
redox mechanism.
Nitric oxide functions as a signal transducer that contributes
to various biological processes in mammals, including vasodi-
lation, the immune response, and synaptic transmission (1–4).
This diffusible free radical is produced by nitric-oxide synthase
(NOS),1 the mammalian isoforms of which are categorized as
type I or type II (4, 5). The type I enzymes include endothelial
NOS and neuronal NOS. These isoforms are expressed consti-
tutively, and their enzymatic activities are regulated by Ca2-
calmodulin (1, 6). The type II enzyme is inducible NOS (iNOS),
the expression of which is induced in many cell types, including
macrophages, astrocytes, and fibroblasts, in response to cyto-
kines or lipopolysaccaride (7–11). The activity of iNOS is inde-
pendent of intracellular Ca2 concentration (12).
NO plays an important role in intracellular and intercellular
signaling events by regulating the activities of various proteins.
It regulates many of these target proteins through S-nitrosyla-
tion. For example, through direct S-nitrosylation, NO activates
Ras and the ryanodine receptor (13, 14) as well as inhibits
caspase-3, c-Jun NH2-terminal kinase (JNK), NF-B, protein
kinase C, and N-methyl-D-aspartate receptor for glutamate (15–
19). S-Nitrosylation is thus responsible for both positive and
negative regulation of diverse signaling pathways by NO (20).
Apoptosis signal-regulating kinase 1 (ASK1) is a serine/thre-
onine protein kinase that functions as a MAPK kinase kinase
in the JNK (also known as stress-activated protein kinase or
stress-activated protein kinase) and p38 MAPK signaling path-
ways (21). ASK1 is activated by exposure of cells to various
stimuli, including tumor necrosis factor-, Fas ligand, hydro-
gen peroxide, genotoxic agents, microtubule-interfering drugs,
and osmotic stress (21, 22). Activation of ASK1 is associated
with apoptotic cell death under various conditions (21–23), but
it is also implicated in other cellular events such as cell prolif-
eration and differentiation (24, 25). Many lines of evidence
suggest that the activity of ASK1 is regulated by physical
interaction with proteins including 14-3-3, thioredoxin, glu-
taminyl-tRNA synthetase, glutathione S-transferase Mu, and
p21 (also known as Cip1 or WAF1) (26–30).
NO regulates the stress-activated MAPK pathways (31–35).
To provide further insight into the mechanism underlying this
regulation, we have investigated the possible effect of NO on
ASK1 signaling. We now show that the induction of iNOS and
the subsequent production of endogenous NO inhibit ASK1
activation though a thiol-redox mechanism. Our observations
thus suggest that ASK1 is a physiological target of NO.
EXPERIMENTAL PROCEDURES
Cell Culture and Transfection—Murine fibrosarcoma L929 and
HEK293 cells were maintained under an atmosphere of 5% CO2 at
37 °C in Dulbecco’s modified Eagle’s medium supplemented with 10%
fetal bovine serum. For DNA transfection, cells in 100-mm dishes (1 
106 cells/dish) were transfected with the indicated plasmid vectors
either with the use of GenePORTER 2 (Gene Therapy Systems) or by
electroporation (Gene Pulser II; Bio-Rad).
Site-directed Mutagenesis—Site-directed mutagenesis of human
ASK1 cDNA was performed with a QuikChange kit (Stratagene) and
the following mutagenic primers: C835S, 5-GCTGGCATAAACCCCa-
GTACTGAAACTTTTACTGG-3; C869S, 5-CTGGTCTCTGGGCaGTA-
CAATCATTGAAATGGCC-3; C918S, 5-GGCCAAGGCATTCATACTG-
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AAAaGTTTTGAACCAGATCC-3; and C928S, 5-CCTGACAAGAGAG-
CCaGTGCTAACGACTTGC-3 (mismatches with the ASK1 cDNA
template are indicated by lowercase letters). The mutations were veri-
fied by automatic DNA sequencing.
Measurement of NO Production—NO production was measured with
a kit based on the Griess reaction (Promega) (19).
Immune Complex Kinase Assays—Immune complex kinase assays
were performed as previously described (19, 36). In brief, the cells were
solubilized with lysis buffer (36), and the lysates were centrifuged at
12,000  g for 10 min at 4 °C. The resulting supernatants were sub-
jected to immunoprecipitation with appropriate antibodies, and the
immunoprecipitates were assayed for the enzymatic activities of the
indicated protein kinases. Phosphorylated substrates were separated
by SDS-polyacrylamide gel electrophoresis, and the extent of their
phosphorylation was quantified with a Fuji BAS 2500 PhosphoImager.
Protein concentration was determined by the Bradford assay (Bio-Rad).
FIG. 1. IFN--induced NO production inhibits H2O2-induced activation of ASK1 in L929 cells. A, L929 cells were incubated for the
indicated times with IFN- (100 units/ml), after which NO released into the culture medium was determined by the Griess method. B, L929 cells
were incubated with or without IFN- (100 units/ml) for 16 h and then for 30 min in the absence or presence of 2 mM L-NNA. The cells were then
left unexposed or exposed to 2 mM H2O2 for 20 min. Cell lysates were subjected to immunoprecipitation with anti-ASK1 antibody, and the resulting
precipitates were examined for ASK1 activity by immune complex kinase assay with GST-MKK6(K82A) as substrate. The fold activation of ASK1
is indicated below each lane. The amount of ASK1 present in cell lysates was revealed by immunoblot analysis (IB) with anti-ASK1 antibody.
FIG. 2. Inhibition of the H2O2-induced activation of both p38 MAPK and ATF2 by the IFN--induced production of NO in L929 cells.
A, L929 cells were transfected for 48 h with an expression vector encoding p38-FLAG, after which they were incubated for 16 h with or without
IFN- (100 units/ml) and then for 30 min in the absence or presence of 2 mM L-NNA. The cells were then left unexposed or exposed to 2 mM H2O2
for 20 min. The cell lysates were subjected to immunoprecipitation with anti-FLAG antibody, and the resulting precipitates were assayed for the
kinase activity of p38 with a GST-ATF2 fusion protein as substrate. B, L929 cells were transfected for 48 h with pFR-Luc, pFA2-ATF2, and
pcDNA3-gal together with expression vectors encoding ASK1 and MKK6(K82A), as indicated. The transfected cells were incubated for 16 h in the
absence or presence of IFN- (100 units/ml) and then for 6 h without or with 2 mM L-NNA. The cell lysates were assayed for luciferase and
-galactosidase activities. Luciferase activity was normalized by -galactosidase activity and then expressed in relative terms. IB, immunoblot.
Thiol Redox Regulation of ASK1 by Nitric Oxide 7585
 at Y
O
N
SEI U
N
IV
ERSITY
 on July 10, 2014
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
Luciferase Reporter Assay for ATF2-dependent Transcription—The
transactivation activity of ATF2 was measured with the use of a Path-
Detect luciferase reporter kit (Stratagene). Briefly, L929 cells were trans-
fected for 48 h with pFR-Luc, pFA2-ATF2, pcDNA3--galactosidase, and
the indicated expression vectors. After treatment with the indicated
agents, the cells were lysed, and cell lysates were assayed for both lucif-
erase and -galactosidase activities as described previously (36). The
luciferase activity was normalized relative to the -galactosidase activity
of the same cells.
Co-immunoprecipitation Analysis—HEK293 cells were transiently
transfected with expression vectors encoding c-Myc epitope-tagged
wild-type ASK1 or ASK1(C869S) and HA-tagged MKK3. After 48 h of
transfection, the cells were untreated or treated for 1 h with 100 M
S-nitro-N-acetyl-DL-penicillamine (SNAP). The cell lysates were sub-
jected to immunoprecipitation with mouse monoclonal anti-c-Myc anti-
body, and the resulting immunoprecipitates were immunoblotted with
mouse monoclonal anti-HA antibody (27, 36).
Measurement of S-Nitrosylation—S-Nitrosylation of endogenous
ASK1 was measured as described previously (19). Briefly, the cells were
exposed to interferon- (IFN-) (100 units/ml) for 16 h at 37 °C and then
lysed. The cell lysates were subjected to immunoprecipitation with rabbit
preimmune IgG or rabbit polyclonal antibody to ASK1 (Santa Cruz Bio-
technology). The resulting precipitates were rinsed five times with lysis
buffer and twice with phosphate-buffered saline. The precipitates were
then incubated for 30 min at room temperature with 100 M HgCl2 and
200 M 2,3-diaminonaphthalene before the addition of 1 M NaOH. A
fluorescent triazole generated from the reaction between 2,3-diamino-
naphthalene and NO released from S-nitrosylated ASK1 was quantified
with a spectrofluorometer (PerkinElmer Life Sciences HTS 7000) at ex-
citation and emission wavelengths of 375 and 450 nm, respectively.
RESULTS AND DISCUSSION
NO Mediates IFN--induced Inhibition of ASK1 in L929
Cells—Like many cytokines, IFN- induces the expression of
iNOS, and thereby increases the intracellular concentration of
NO, in macrophages and other cell types (37). IFN- thus
increased the production of NO in murine fibrosarcoma L929
cells (Fig. 1A). We investigated the possible effect of NO on
ASK1-mediated signaling in L929 cells. Exposure of these cells
to H2O2 resulted in the activation of endogenous ASK1, and
pretreatment of the cells with IFN- blocked this effect of H2O2
(Fig. 1B). The inhibitory effect of IFN- was abolished by NG-
nitro-L-arginine (L-NNA), an inhibitor of NOS. These results
thus suggest that IFN- inhibits ASK1 activation in L929 cells
and that this effect is mediated by NO.
We next examined the effect of IFN- on the kinase activity
of p38, a downstream MAPK of ASK1, in L929 cells that had
been transfected with a plasmid encoding FLAG epitope-tagged
p38 (p38-FLAG). IFN- inhibited the H2O2-induced activation
of p38 in the transfected cells, and this inhibitory effect was
blocked by L-NNA (Fig. 2A). These data suggest that the IFN-
-induced production of NO was responsible for the inhibition
of p38 MAPK activity by this cytokine. The effect of IFN--
induced NO production on the transactivation activity of ATF2
was also examined with a luciferase reporter system (Fig. 2B).
ATF2 is a physiological substrate of p38, and its phosphoryla-
tion by this kinase increases its transcription-stimulating ac-
tivity (38). Overexpression of ASK1 resulted in a marked in-
crease in ATF2-dependent luciferase reporter activity, and this
effect was blocked by co-expression of a dominant-negative
mutant (MKK6(K82A)) of MKK6, which functions as a MAP2K
upstream of p38 (39). These results indicated that the ASK1-
induced activation of ATF2 was mediated by the p38 MAPK
signaling pathway. IFN- also inhibited the ASK1-induced ac-
tivation of ATF2, and this inhibitory effect of IFN- was
blocked by L-NNA. The IFN--induced production of NO thus
appeared to be responsible for the inhibition of the ASK1-de-
pendent activation of ATF2 by this cytokine in L929 cells.
SNAP Inhibits ASK1 Activity in Vitro—Some of the biologi-
cal functions of NO are mediated through the activation of
guanylyl cyclase, which catalyzes the production of cyclic GMP
(37, 40). We therefore examined whether guanylyl cyclase and
cyclic GMP mediate the inhibition of ASK1 by NO produced in
response to IFN- in L929 cells. Pretreatment of the cells with
1H-(1,2,4)oxadiazolo[4,3-a]quinoxalin-1-one, an inhibitor of
guanylyl cyclase, did not block the inhibitory effect of IFN- on
the H2O2-induced activation of ASK1 (Fig. 3A). Furthermore,
pretreatment of the cells with 8-bromo-cyclic GMP, a cell-per-
meable analog of cyclic GMP, did not inhibit the H2O2-induced
activation of ASK1 (Fig. 3B). These results thus suggested that
cyclic GMP was not responsible for the inhibition of ASK1
activation by NO produced in response to IFN- in L929 cells.
We next investigated whether NO was able to inhibit ASK1
directly. We examined the effect of the NO donor SNAP on the
activities of ASK1, MKK3, MKK6, and p38 in vitro. SNAP
inhibited the kinase activity of ASK1 that had been isolated
from H2O2-treated L929 cells by immunoprecipitation (Fig.
4A). In contrast, SNAP did not affect the kinase activities of
MKK3, MKK6, or p38. SNAP also did not inhibit the activity of
MEKK1 in vitro (data not shown). The thiol-reducing agents
dithiothreitol and -mercaptoethanol each reversed the inhib-
itory effect of SNAP on ASK1 activity in vitro (Fig. 4B). These
data thus suggest that ASK1 is a direct target of NO and that
FIG. 3. Cyclic GMP is not involved
in the NO-induced inhibition of ASK1
activity in L929 cells. A, L929 cells
were transfected for 48 h with an expres-
sion vector encoding ASK1-FLAG. The
transfected cells were incubated for 16 h
with or without IFN- (100 units/ml) and
then for 30 min in the absence or presence
of 100 M 1H-[1,2,4]oxadiazolo[4,3-a]qui-
noxalin-1-one before exposure to 2 mM
H2O2 for 20 min. The cell lysates were
subjected to immunoprecipitation with
anti-FLAG antibody, and the resulting
precipitates were assayed for ASK1 activ-
ity. B, L929 cells were transfected for 48 h
with the ASK1-FLAG vector, incubated in
the absence or presence of 100 M 8-bro-
mo-cyclic GMP (8-Br-cGMP) for 30 min
and then left unexposed or exposed to 2
mM H2O2 for 20 min. The cells were then
assayed for ASK1 activity as in A. IB,
immunoblot.
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NO inhibits ASK1 activity by a thiol-redox mechanism. We
further investigated the thiol-redox regulation of ASK1 by ex-
amining the effects of N-ethylmaleamide, a thiol-modifying
reagent, as well as of azodicarboxylic acid bis-dimethylamide
(Diamide) and o-iodosobenzoate, each of which oxidizes vicinal
thiols (41–43). N-Ethylmaleimide, Diamide, and o-iodosoben-
zoate all inhibited ASK1 activity in vitro (Fig. 5). Taken to-
gether, these data suggest that the kinase activity of ASK1 is
dependent on the reduced form of a critical cysteine residue (or
residues) present in the protein.
NO Targets the Kinase Domain of ASK1—To characterize
further the inhibition of ASK1 by NO, we examined the effects
of NO on the kinase activities of two mutants of ASK1,
ASK1-N and ASK1-K. ASK1-N is a constitutively active
form of ASK1 that encodes amino acids 649–1375 of the protein
(27), whereas ASK1-K encodes amino acids 678–936 of ASK1,
which include the kinase domain. INF- inhibited the kinase
activities of HA-tagged ASK1-N and HA-tagged ASK1-K ex-
pressed in L929 cells (Fig. 6). SNAP also inhibited the activities
of ASK1-N and ASK1-K in vitro (Fig. 6). These data suggest
that the kinase domain of ASK1 includes the target site (or
sites) of NO. The thiol-oxidizing agents N-ethylmaleimide, Dia-
mide, and o-iodosobenzoate also inhibited ASK1-K activity in
vitro (data not shown).
Cys869 of ASK1 Is Required for Thiol Redox Regulation by
NO—The kinase domain of ASK1 contains four cysteine resi-
dues: Cys835, Cys869, Cys918, and Cys928. To identify the cys-
teine residue (or residues) targeted by NO, we constructed
mutant proteins in which each of these four residues is indi-
vidually replaced with serine (C835S, C869S, C918S, and
FIG. 4. SNAP inhibits ASK1 in vitro.
A, L929 cells were transfected for 48 h
with an expression vector encoding ASK1-
FLAG, HA-MKK3, HA-MKK6, or p38-
FLAG. The cells were then incubated in
the absence or presence of 2 mM H2O2 for
20 min. The cell lysates were subjected to
immunoprecipitation with antibodies to
FLAG or to HA. The immunoprecipitates
were left unexposed or exposed to 100 M
SNAP for 20 min on ice and then assayed
for the indicated protein kinase activities.
B, ASK1-FLAG immunoprecipitates pre-
pared as in A were left unexposed or ex-
posed to 100 M SNAP for 20 min on ice
and then incubated for 20 min on ice with-
out or with 10 mM dithiothreitol (DTT) or
10 mM -mercaptoethanol (-ME). The
precipitates were washed three times
with 20 mM Hepes (pH 7.4) and then as-
sayed for ASK1 activity.
FIG. 5. Thiol-reactive agents inhibit ASK1 in vitro. L929 cells were transfected for 48 h with an expression vector for ASK1-FLAG and then
incubated in the absence or presence of 2 mM H2O2 for 20 min. The cell lysates were subjected to immunoprecipitation with antibodies to FLAG.
The resulting precipitates were incubated for 20 min on ice in the absence or presence of 500 M N-ethylmaleimide (NEM), 500 M Diamide, or
500 M o-iodosobenzoate (o-IBZ) and then examined for ASK1 activity by immune complex kinase assay.
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C928S) and then examined their sensitivity to NO. SNAP in-
hibited the kinase activities of the C835S, C918S, and C928S
mutants of ASK1-K in vitro (Fig. 7A). In contrast, the C869S
mutant was resistant to the inhibition by SNAP. These results
suggest that Cys869 of ASK1 is the cysteine residue targeted by
NO. Next, we transfected L929 cells with an expression vector
for FLAG-tagged wild-type ASK1 or ASK1(C869S) and then
examined the effect of INF- on the H2O2-induced activation of
the ectopically expressed ASK1 proteins. INF- inhibited the
H2O2-induced increase in the activity of ASK1 but not that in
the activity of ASK1(C869S) (Fig. 7B). Together, these data
suggest that NO produced in response to INF- inhibits ASK1
activity through modification of Cys869 of the kinase.
We next investigated a possible mechanism by which the
targeting of NO on Cys869 of ASK1 resulted in the inhibition of
the kinase activity. We examined whether NO production could
block the interaction between ASK1 and its substrate MKK3
after HEK293 cells were transfected with plasmid vectors en-
coding HA-tagged MKK3 and c-Myc epitope-tagged ASK1 or
ASK1(C869S). Immunoblot analysis with anti-HA antibody of
FIG. 7. Identification of Cys869as a
target for NO in the thiol-redox reg-
ulation of ASK. A, L929 cells were trans-
fected for 48 h with an expression vector
encoding a HA-tagged cysteine mutant of
ASK1-K (C835S, C869S, C918S, or
C928S). The cell lysates were subjected to
immunoprecipitation with anti-HA anti-
body. The resulting precipitates were in-
cubated for 20 min on ice in the absence or
presence of 100 M SNAP and then as-
sayed for ASK1 activity. B, L929 cells
were transfected for 48 h with an expres-
sion vector encoding ASK1-FLAG or
ASK1(C869S)-FLAG, incubated for 16 h
in the absence or presence of IFN- (100
units/ml), and then left unexposed or ex-
posed to 2 mM H2O2 for 20 min. The cell
lysates were subjected to immunoprecipi-
tation with anti-FLAG antibody, and the
resulting precipitates were examined for
ASK1 activity by immune complex kinase
assay. The cell lysates were also analyzed
by immunoblotting (IB) with anti-FLAG
antibody.
FIG. 6. NO inhibits ASK1-N and
ASK1-K. L929 cells were transfected for
48 h with an expression vector encoding
HA-tagged ASK1-N (A) or HA-tagged
ASK1-K (B). Where indicated, the cells
were then incubated in the absence or
presence of IFN- (100 units/ml) for 16 h.
The cell lysates were subjected to immu-
noprecipitation with anti-HA antibody,
and the resulting precipitates were exam-
ined for ASK1 activity by immune com-
plex kinase assay. Where indicated, the
precipitates were incubated for 20 min on ice
in the absence or presence of 100 M SNAP
prior to the immune complex kinase assay
for ASK1 activity. IB, immunoblot.
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the c-Myc immunoprecipitates indicated that treatment of the
cells with SNAP inhibited the interaction between ASK1 and
MKK3. In contrast, SNAP did not affect the interaction be-
tween ASK1(C869S) and MKK3 (Fig. 8A). SNAP also inhibited
the interaction between ASK1 and its another substrate
MKK6, whereas it did not affect the interaction between
ASK1(C869S) and MKK6 (Fig. 8B). Our results thus suggest
that the suppression of the interaction between ASK1 and its
substrate kinases is involved in the mechanism underlying the
inhibition of ASK1 by NO.
IFN- Enhances the S-Nitrosylation of Endogenous ASK1 in
L929 Cells—We next investigated whether the INF--induced
production of NO results in the S-nitrosylation of ASK1 in L929
cells. The cells were transfected with an expression vector for
FIG. 9. IFN-enhances S-nitrosylation of ASK1 in L929 cells. A, L929 cells were transfected with an expression vector encoding HA-tagged
ASK1-K or ASK1-K(C869S). After 48 h of transfection, the cells were incubated for 16 h in the absence or presence of IFN- (100 units/ml). The
cell lysates were precleared with the use of mouse preimmune IgG and then subjected to immunoprecipitation (IP) with mouse monoclonal anti-HA
antibody. The resulting immunoprecipitates were incubated with 200 M HgCl2 and 200 M 2,3-diaminonaphthalene for 30 min at room
temperature and then added with 1 M NaOH. NO released from S-nitrosylated ASK1 was quantified by fluorometry. B, L929 cells were incubated
with IFN- (100 units/ml) and analyzed as in A, with the exception that immunoprecipitation was performed with either preimmune rabbit IgG
or rabbit polyclonal antibodies to ASK1, and both of the resulting precipitates were assayed for S-nitrosylation. These data represent the results
from three independent experiments.
FIG. 8. The effect of SNAP on the binding of ASK1 or ASK1(C869S) to MKK3 or MKK6. HEK293 cells were transfected for 48 h with
plasmid vectors encoding c-Myc epitope-tagged ASK1 (ASK1-myc) or ASK1(C869S)-Myc along with HA-MKK3 (A) or HA-MKK6 (B). The
transfected cells were untreated or treated for 1 h with 100 M SNAP, and the cell lysates were subjected to immunoprecipitation (IP) with mouse
monoclonal anti-c-Myc antibody. The resulting immunoprecipitates were subjected to immunoblot analysis with mouse monoclonal anti-HA
antibody. The cell lysates were also directly subjected to immunoblot (IB) analysis with an antibody to c-Myc or HA.
Thiol Redox Regulation of ASK1 by Nitric Oxide 7589
 at Y
O
N
SEI U
N
IV
ERSITY
 on July 10, 2014
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
HA-tagged ASK1-K or ASK1-K(C869S) and then treated with
INF-, after which immunoprecipitates of the recombinant
proteins analyzed for S-nitrosylation by fluorometry with
2,3-diaminonaphthalene (19). INF- increased the extent of
S-nitrosylation of ASK1-K but not that of ASK1-K(C869S)
(Fig. 9A). These results suggest that INF- treatment en-
hances the S-nitrosylation of Cys869 of ASK1 in intact cells.
Finally, we examined the effect of INF- on the S-nitrosyla-
tion of endogenous ASK1 in L929 cells. INF- also increased
the extent of S-nitrosylation of the endogenous protein
(Fig. 9B).
NO, an endogenous thiol-reactive agent, modifies many reg-
ulatory proteins by a thiol-redox mechanism and thereby mod-
ulates their biological functions (13–19). We have now shown
that ASK1 is a target protein of NO and that NO acts at a site
in the kinase domain of ASK1. Although NO exerts some of its
biological effects by activating guanylyl cyclase and thereby
inducing the accumulation of cyclic GMP, guanylyl cyclase and
cyclic GMP do not appear to contribute to the negative regula-
tion of ASK1 by NO. NO inhibits the activity of ASK1 both in
vitro and in intact cells by a thiol-redox mechanism. Further-
more, site-directed mutagenesis revealed that Cys869 is the
redox-sensitive cysteine residue of ASK1. IFN-, by inducing
the expression of iNOS and the consequent production of NO,
induces S-nitrosylation of endogenous ASK1 and thereby in-
hibits ASK1 activation in L929 cells. Collectively, our results
indicate that NO functions as a physiological inhibitor of ASK1.
It is noteworthy that H2O2 does not inhibit ASK1 activity in
vitro (data not shown). Furthermore, replacement of Cys869 of
ASK1 by serine has no inhibitory effect on the kinase activity of
the protein. Our findings thus strongly suggest that the inhi-
bition of ASK1 by S-nitrosylation results from the presence of
a nitrosyl group not from the absence or a simple oxidation of a
sulfhydryl group, at Cys869. Cys869 is located in the catalytic
domain of ASK1, where Asp803 functions as the catalytic as-
partate and the activation loop spans the region between
Asp822 and Glu849 (44, 45). The activation loop includes Thr838
and Thr842, the phosphorylation sites of ASK1 (45). Autophos-
phorylation of Thr838, in particular, is required for ASK1 acti-
vation (45). Phosphorylation within the activation loop of a
protein kinase induces a conformational change that may allow
better access of a substrate to the catalytic site (44, 46). One
intriguing question is whether S-nitrosylation at Cys869 im-
pedes autophosphorylation of Thr838. Further studies are
needed to investigate a possibility that the inhibition of Thr838
autophosphorylation by S-nitrosylation at Cys869 might be the
mechanism by which NO suppresses a physical association
between ASK1 and its substrates.
NO regulates stress-activated MAPK signaling pathways
under various conditions (31–35). Given that ASK1 is a proxi-
mal component of such signaling pathways that result in the
activation of JNK or p38, the thiol-redox regulation of ASK1 by
NO may be an efficient means by which to modulate the activ-
ities of these pathways. We also recently showed that NO
inhibits JNK through S-nitrosylation of a specific cysteine res-
idue in this protein (19). Our previous and present findings
together thus suggest that NO regulates stress-activated sig-
naling by S-nitrosylation of two target proteins: ASK1 and
JNK. Our present results also suggest that the negative regu-
lation of ASK1 by IFN- might contribute to some of the bio-
logical effects of this cytokine in cells that express iNOS.
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